Kenvue Inc. Common Stock vs Planet Labs — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while Planet Labs trades at $17.18 (market cap $6.25B). The key difference: Kenvue Inc. Common Stock is far larger — about 5.4× Planet Labs's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Planet Labs pays none. Which is the better fit depends on your goals.
| KVUE | PL | |
|---|---|---|
Market Cap | $34.06B | $6.25B |
Volume | 23,267,228 | 19,125,340 |
Sector | Consumer Staples | Industrials |
52-Week High | $19.83 | $51.40 |
52-Week Low | $14.11 | $11.16 |
Enterprise Value | $41.56B | $5.89B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 4 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →